We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+9.95%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$39.9B
AUM Growth
+$891M
(+2.3%)
Cap. Flow
-$1.96B
Cap. Flow
% of AUM
-4.91%
Top 10 Holdings %
Top 10 Hldgs %
26.01%
Holding
846
New
122
Increased
198
Reduced
391
Closed
98
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$171M |
| 2 |
Sensata Technologies
ST
|
+$145M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$133M |
| 4 |
Amazon
AMZN
|
+$67.2M |
| 5 |
AbbVie
ABBV
|
+$65.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Otis Worldwide
OTIS
|
+$164M |
| 2 |
Ross Stores
ROST
|
+$110M |
| 3 |
Bank of America
BAC
|
+$94.4M |
| 4 |
Freeport-McMoran
FCX
|
+$92.4M |
| 5 |
Five Below
FIVE
|
+$89.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.1% |
| 2 | Healthcare | 19.47% |
| 3 | Consumer Discretionary | 12.58% |
| 4 | Financials | 11.29% |
| 5 | Communication Services | 8.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Intuitive Surgical
ISRG
$133B
| $85.8M | 0.21% |
362,832
-132,852
| -27% | -$29.8M |
|
102
Louisiana-Pacific
LPX
$5.4B
| $84.3M | 0.21% |
2,857,877
+316,147
| +12% | +$9.71M |
|
103
Cognizant
CTSH
$25.1B
| $84.3M | 0.21% |
1,213,750
+632,900
| +109% | +$41.2M |
|
104
Prologis
PLD
$131B
| $83.2M | 0.21% |
827,229
-28,800
| -3% | -$2.89M |
|
105
Chubb
CB
$136B
| $82.2M | 0.21% |
708,224
-119,400
| -14% | -$15M |
|
106
Owens Corning
OC
$12.3B
| $82M | 0.21% |
1,191,212
-80,519
| -6% | -$5.16M |
|
107
Altria Group
MO
$114B
| $80.9M | 0.2% |
2,093,432
-50,700
| -2% | -$2.11M |
|
108
Blackrock
BLK
$176B
| $79.8M | 0.2% |
141,680
-36,600
| -21% | -$20.9M |
|
109
Vertex Pharmaceuticals
VRTX
$123B
| $79.2M | 0.2% |
290,990
-108,662
| -27% | -$30M |
|
110
Booking.com
BKNG
$160B
| $79M | 0.2% |
1,155,000
-25,000
| -2% | -$1.76M |
|
111
Crown Castle
CCI
$32.3B
| $78.2M | 0.2% |
469,760
+265,601
| +130% | +$43.8M |
|
112
L3Harris
LHX
$53.3B
| $77.9M | 0.2% |
458,847
+38,522
| +9% | +$6.76M |
|
|
BECN
113
DELISTED
Beacon Roofing Supply, Inc.
BECN
| $77.9M | 0.2% |
2,506,878
-1,092,838
| -30% | -$33M |
|
114
Air Products & Chemicals
APD
$65.7B
| $77.8M | 0.19% |
261,358
+26,900
| +11% | +$7.74M |
|
115
Southwest Airlines
LUV
$23.9B
| $77.4M | 0.19% |
2,064,494
+1,295,817
| +169% | +$46M |
|
116
Stryker
SYK
$129B
| $76.2M | 0.19% |
365,774
-7,500
| -2% | -$1.46M |
|
117
AES
AES
$10.5B
| $75.9M | 0.19% |
4,189,433
+900,900
| +27% | +$15M |
|
118
Elevance Health
ELV
$84.8B
| $75.8M | 0.19% |
282,393
-9,500
| -3% | -$2.56M |
|
119
Equinix
EQIX
$104B
| $75.4M | 0.19% |
99,168
-3,100
| -3% | -$2.35M |
|
120
TJX Companies
TJX
$177B
| $74.3M | 0.19% |
1,335,153
-955,511
| -42% | -$51.5M |
|
121
Colgate-Palmolive
CL
$74.4B
| $73.9M | 0.18% |
957,620
-31,500
| -3% | -$2.4M |
|
122
Dominion Energy
D
$60B
| $72.9M | 0.18% |
924,056
+180,190
| +24% | +$14.2M |
|
123
Duke Energy
DUK
$96.2B
| $72.8M | 0.18% |
822,160
+293,400
| +55% | +$24.2M |
|
124
CenterPoint Energy
CNP
$26.8B
| $72.6M | 0.18% |
3,749,829
-3,308,410
| -47% | -$64.9M |
|
125
Amphenol
APH
$212B
| $72.5M | 0.18% |
2,680,336
-1,152,000
| -30% | -$30.4M |
|
Similar funds
Adage Capital Partners's Q3 2020 Portfolio in Review
As of Q3 2020, Adage Capital Partners held 846 positions worth $39.9B, up 2.3% from $39.1B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Adage Capital Partners withdrew a net $1.96B in Q3 2020, closing 98 positions and reducing 391 holdings. Its most notable exit was Pfizer, an estimated $60.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Adage Capital Partners opened a new position in Bristol-Myers Squibb worth $134M.
- Adage Capital Partners's largest Q3 2020 buy was Bristol-Myers Squibb: 2,215,804 shares worth $134M.
- Adage Capital Partners added most to Johnson & Johnson in Q3 2020, an estimated $171M increase.
- Adage Capital Partners's biggest Q3 2020 reduction was Otis Worldwide, cutting an estimated $164M.
- Adage Capital Partners fully exited Pfizer in Q3 2020, selling an estimated $60.9M.
- Adage Capital Partners's ten largest holdings make up 26% of its $39.9B portfolio in Q3 2020.
- Adage Capital Partners opened 122 new positions and closed 98 in Q3 2020.
- Adage Capital Partners's portfolio value rose 2.3% quarter-over-quarter to $39.9B.
Based on Adage Capital Partners's 13F filing for Q3 2020, filed 16 Nov 2020.